Despite COVID-19, we are operating at full capacity and all project work is operating as usual.

Clinically predictive preclinical efficacy testing services at your disposal

MARCH 7, 2014

Pharmatest Services Ltd launches new products in AACR Annual Meeting in San Diego

Pharmatest Services Ltd attends Annual Meeting of American Association for Cancer Research (AACR) held in San Diego, CA, USA on April 5 – 9, 2014. Pharmatest attends the event with a booth and scientific presentations and launches new service products in the meeting.

Pharmatest Services Ltd (Pharmatest) is a contract research organization that offers preclinical efficacy services for the pharmaceutical industry in the fields of oncology and skeletal diseases. The Annual Meeting of AACR is the leading scientific event in the field of cancer research globally, with over 17,000 expected participants from 60 countries.

This year Pharmatest attends AACR with three scientific presentations that demonstrate efficacy of customer compounds for cancer treatment. The studies were performed in collaboration with Bayer Pharma AG, Exelixis Inc. and Virobay Inc. that all have credited Pharmatest (see Customer testimonials). Pharmatest also welcomes everyone to visit our booth #848.

Pharmatest launches new cancer models that are available for our customers as service products after the event. The new models include robotics-based in vitro high throughput screening and patient-derived xenograft models.

Jussi Halleen, CEO of Pharmatest says: “We are happy to present again new exiting data with our customers in AACR, and I am proud for the launching of the new products that complement our existing products and help us to serve our customers better with a wider range of services in the coming years.”

If you would like to meet our representative during the AACR meeting, click here.